Innovating patent research with highly comprehensive sequence searches.
PatSnap's Bio, specialized in the pharmaceutical, biotechnology, and agriculture industries, identifies patent information and a wealth of non-patent literature resources through the search of DNA, RNA, and protein sequences. It integrates with PatSnap's patent search and analysis tool, Analytics, allowing for more detailed patent analysis. Advanced data processing technology and a unique search AI algorithm significantly improve the FTO of biological sequences and reduce the risk of search omissions. 【Features】 ■ Large-scale sequence database Utilizes a highly comprehensive sequence database extracted from millions of patents, literature, and public databases through manual and AI methods. ■ Degenerate sequence search With cutting-edge degenerate search technology and proprietary AI, it enables degenerate sequences with various combinations. This enhances search comprehensiveness and reduces risk. ■ Extensive sequence search options Includes numerous sequence search options such as antibodies, motifs, fragments, and bulk searches of multiple sequences.
Inquire About This Product
Related Videos
basic information
■Coverage: Number of recorded sequences: Patent-derived sequences: 89,293,000, Literature-derived sequences: 4,890,000, Patents containing sequences: 1,980,000 reports, Literature containing sequences: 2,490,000 reports (as of May 2024) Applicable jurisdictions: 80 ■Sequence Search - Sequence search (bulk search of up to 200 sequences), antibody search, motif search, fragment search ■Degenerate Sequence Search - Enables the search of over 1 trillion sequences in our degenerate library, which includes many degenerate codes or variable residues that are not easily searchable using conventional search algorithms due to low similarity scores. Our unique search algorithm significantly reduces the risk of missing important sequences in searches. ■Search for Chemical Modifications - Supports two search modes: one for searching all sequences with the desired modification, and another for searching similar sequences with pre-set modifications. This facilitates the analysis of chemical modifications for drug design and process optimization. ■Format Conversion of Sequence Files - Conversion from EMBL to FASTA, GenBank to FASTA, removal of unnecessary characters (extracting only DNA and protein sequences), conversion between single-letter and three-letter notation, conversion to complementary sequences. Others.
Price range
P5
Delivery Time
P3
Applications/Examples of results
**Purpose** ■ Novelty and third-party patent infringement investigation (FTO investigation) We search the world's most comprehensive large-scale sequence database to ensure that potential infringement risks are not overlooked. By utilizing degenerate sequence searches that do not typically yield hits in standard searches, we enable highly reliable investigations. ■ Identification of sequences with pharmacological activity Based on the provided information about specific targets/drug names or functions, we search for global biological sequences that meet the criteria and analyze their development status. ■ Keeping track of competitors' trends We conduct comprehensive biological sequence landscape analyses to monitor competitors and determine whether they are working on similar sequences or entering new fields. ■ Pursuing new frontiers in bio-innovation We gain insights into the potential functions of unknown sequences and explore new research activities around the world.
catalog（4）
Download All Catalogs
News about this product（1）
![[Free Webinar] Manual Curation Techniques for Accelerating AI/ML Drug Discovery Using SAR and ADME Data | Held on June 11 (Thursday)](https://image.mono.ipros.com/public/news/image/1/2054179/IPROS8065780838779876503.png?w=280&h=280)
Company information
Patocoa Inc. is a specialized company in drug discovery support systems. Additionally, we focus on improving and streamlining compliance-related operations concerning regulated substances, and we have provided various solutions to pharmaceutical companies, chemical companies, universities, and government agencies. We contribute to accelerating drug discovery and reducing costs with our cutting-edge chemoinformatics systems.